A $16 Billion Fund’s Favorite Healthcare Stocks in Third Quarter

Wall St. Watchdog reveals information regarding Epoch Investment Partners’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 22 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $1.54 billion.

  • Laboratory Corp. Of America Holdings (NYSE:LH): On 06/30/2011 reported holding 2,758,510 shares with a market value of $266,996,185. This comprised 2.01% of the total portfolio. On 09/30/2011 reported holding 2,903,030 shares with a market value of $229,484,530. This comprised 1.93% of the total portfolio. The net change in shares for this position over the two quarters is 144,520. About Company: Laboratory Corporation of America Holdings is a clinical laboratory organization. The Company offers a wide range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. Laboratory Corporation operates a network of laboratories and service sites which serve clients across the United States.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011 reported holding 3,360,343 shares with a market value of $176,821,245. This comprised 1.33% of the total portfolio. On 09/30/2011 reported holding 3,734,160 shares with a market value of $190,964,940. This comprised 1.6% of the total portfolio. The net change in shares for this position over the two quarters is 373,817. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011 reported holding 4,247,384 shares with a market value of $219,080,074. This comprised 1.65% of the total portfolio. On 09/30/2011 reported holding 4,031,180 shares with a market value of $185,918,017. This comprised 1.56% of the total portfolio. The net change in shares for this position over the two quarters is -216,204. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011 reported holding 3,894,742 shares with a market value of $250,782,435. This comprised 1.89% of the total portfolio. On 09/30/2011 reported holding 3,252,287 shares with a market value of $164,695,812. This comprised 1.38% of the total portfolio. The net change in shares for this position over the two quarters is -642,455. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Davita Inc. (NYSE:DVA): On 06/30/2011 reported holding 2,822,685 shares with a market value of $244,472,750. This comprised 1.84% of the total portfolio. On 09/30/2011 reported holding 2,386,434 shares with a market value of $149,557,814. This comprised 1.26% of the total portfolio. The net change in shares for this position over the two quarters is -436,251. About Company: DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure. The Company treats patients through a network of owned and managed dialysis facilities in the continental United States.
  • Aetna Inc. (NYSE:AET): On 06/30/2011 reported holding 3,906,118 shares with a market value of $172,220,743. This comprised 1.3% of the total portfolio. On 09/30/2011 reported holding 3,998,229 shares with a market value of $145,295,642. This comprised 1.22% of the total portfolio. The net change in shares for this position over the two quarters is 92,111. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP): On 06/30/2011 reported holding 3,254,052 shares with a market value of $130,715,263. This comprised 0.98% of the total portfolio. On 09/30/2011 reported holding 3,228,885 shares with a market value of $90,376,490. This comprised 0.76% of the total portfolio. The net change in shares for this position over the two quarters is -25,167. About Company: Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo’s products include Percocet, Percodan, and Lidoderm.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011 reported holding 1,619,023 shares with a market value of $78,069,291. This comprised 0.59% of the total portfolio. On 09/30/2011 reported holding 1,833,100 shares with a market value of $68,227,984. This comprised 0.57% of the total portfolio. The net change in shares for this position over the two quarters is 214,077. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011 reported holding 1,568,024 shares with a market value of $45,409,974. This comprised 0.34% of the total portfolio. On 09/30/2011 reported holding 2,079,166 shares with a market value of $65,244,227. This comprised 0.55% of the total portfolio. The net change in shares for this position over the two quarters is 511,142. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Astrazeneca Plc (NYSE:AZN): On 06/30/2011 reported holding 1,079,201 shares with a market value of $54,035,594. This comprised 0.41% of the total portfolio. On 09/30/2011 reported holding 1,447,990 shares with a market value of $64,232,837. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 368,789. About Company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.

(Note: Data regarding Epoch Investment Partners’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>